84 related articles for article (PubMed ID: 1272771)
1. [Correlation between immunological stage and response to chemotherapy. Results in 64 patients with nonresectable epidermoid bronchial cancers].
Pouillart P; Botto G; Gauthier H; Huguenin P; Baron A; Laparre C; Hoang Thy HT; Parrot R; Mathé G
Nouv Presse Med; 1976 Apr; 5(16):1037-42. PubMed ID: 1272771
[TBL] [Abstract][Full Text] [Related]
2. [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].
Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G; Lededente A; Botto G
Nouv Presse Med; 1978 Jan; 7(4):265-9. PubMed ID: 345229
[TBL] [Abstract][Full Text] [Related]
3. Delayed hypersensitivity in patients with bronchial carcinoma.
Pauwels R; van der Straeten M
Scand J Respir Dis; 1975 Sep; 56(3):160-4. PubMed ID: 1162307
[TBL] [Abstract][Full Text] [Related]
4. [Delayed skin hypersensitivity to 2,4-dinitrochlorobenzene (DNCB) in patients with bronchial carcinoma].
Ruszel KB
Wiad Lek; 1978 Oct; 31(19):1341-4. PubMed ID: 716404
[No Abstract] [Full Text] [Related]
5. [Parameters of cellular immunity in subjects with bronchial squamous cell tumors].
Vietti Ramus G; Tartaglino B; Cesano L; Revello F; Barbalonga A
Minerva Med; 1983 Apr; 74(16):879-87. PubMed ID: 6601781
[TBL] [Abstract][Full Text] [Related]
6. Effect of transfer factor on lymphocyte function in anergic patients.
Kirkpatrick CH; Rich RR; Smith TK
J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
[TBL] [Abstract][Full Text] [Related]
7. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
[TBL] [Abstract][Full Text] [Related]
8. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate in the treatment of malignant tumours: evidence for the possible participation of host defence mechanisms.
Stewart TH; Klassen D; Crook AF
Can Med Assoc J; 1969 Aug; 101(4):191-9. PubMed ID: 5811699
[No Abstract] [Full Text] [Related]
10. A comparison of leukocyte aggregation, leukocyte migration and skin reactivity to recall antigens in patients with AIDS.
Rouveix B; Groult F; Pocidalo JJ
Clin Exp Immunol; 1986 Dec; 66(3):574-81. PubMed ID: 3568448
[TBL] [Abstract][Full Text] [Related]
11. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
Szczylik C; Wiktor-Jedrzejczak W
Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
[TBL] [Abstract][Full Text] [Related]
12. ["Active" rosettes and skin tests to recall antigens and phytohemagglutinin in 48 patients with non metastatic squamous cell lung carcinoma and before treatment (author's transl)].
Lang JM; Pauli G; Roeslin N; Bigel P; Bessot JC
Rev Fr Mal Respir; 1980; 8(1):11-6. PubMed ID: 6970392
[TBL] [Abstract][Full Text] [Related]
13. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
14. [Peripheral T-lymphocytes and delayed hypersensitivity in surgically and radiologically treated patients with early stages of larynx-carcinoma].
Behrens K; Sesterhenn K; Schütt A
HNO; 1982 Jul; 30(7):250-5. PubMed ID: 6981631
[TBL] [Abstract][Full Text] [Related]
15. [Immunological reactivity study of patients with uterine trophoblastic tumors].
Grigorova TM; Stas TA; Kadagidze ZG; Kovaleva VL
Vopr Onkol; 1979; 25(7):86-90. PubMed ID: 225875
[TBL] [Abstract][Full Text] [Related]
16. [Relationships between clinico-therapeutic parameters and immunological status in patients with lung cancer].
Roviaro GC; Varoli F; Sartori F; Calabrò F; Bortolotti F; Tremolada F; Fattovich G; Cecchetto A; Paruzzolo P
Minerva Med; 1980 Jun; 71(25):1757-67. PubMed ID: 6997779
[TBL] [Abstract][Full Text] [Related]
17. Delayed hypersensitivity to DNCB and survival following radiation therapy in patients with solid malignant tumors.
Hazra TA; Parks LC; Inalsingh A; Peeples W
Radiology; 1975 May; 115(2):429-30. PubMed ID: 1144761
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immune response in patients with bronchial carcinoma. Relation between clinical parameters and various immunological tests for immune status investigation.
Jansen HM; Esselink MT; Orie NG; The TH
Neth J Med; 1979; 22(1):1-9. PubMed ID: 216940
[No Abstract] [Full Text] [Related]
19. Characteristics of tumor associated antigens in squamous cell carcinoma.
Krause CJ
Laryngoscope; 1979 Jul; 89(7 Pt 1):1105-20. PubMed ID: 87996
[TBL] [Abstract][Full Text] [Related]
20. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
Maisel RH; Ogura JH
Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
[No Abstract] [Full Text] [Related]
[Next] [New Search]
